The pooled effect size demonstrated significantly higher KL-6 concentrations in the RA-ILD group compared to the RA group (MD = 590.25; 95% CI: 448.65-731.84; P < 0.001), with substantial heterogeneity observed (I2 = 94.60%, P < 0.001). Here, MUC1 is linked to interstitial lung disease.